Dr. Robinson is a board certified rheumatologist on the teaching faculty at Stanford’s School of Medicine and has clinical practices affiliated with Stanford Hospital and the VA Hospital in Palo Alto. He is also a member of the Stanford Lyme Working Group (SLWG). His laboratory studies the molecular mechanisms of and treatments for autoimmune and rheumatic diseases, including rheumatoid arthritis, multiple sclerosis, osteoarthritis, and Lyme disease. The goal is to develop novel therapies for practical patient care, including the application of antibody sequencing technologies for the treatment of Lyme and other autoimmune diseases.
Assoc. Professor , Stanford University Dept. of Medicine (Immunology & Rheumatology)